InstalabLoading...
InstalabLoading...
If you live in central Texas or anywhere in the south central United States and feel like you've been hit by a truck every December and January, mountain cedar may be the reason. The pollen from Ashe juniper, locally called mountain cedar, releases in such heavy bursts during winter that residents describe symptoms as 'cedar fever.' Confirming whether your immune system actually recognizes this specific pollen lets you stop guessing and start treating the right cause.
This test measures IgE (immunoglobulin E), a type of antibody your body makes when it has been sensitized to a specific allergen. A positive result means your immune system has built a recognition program for mountain cedar pollen proteins. That sensitization is what later triggers the runny nose, itchy eyes, and wheezing when you inhale the pollen.
Mountain cedar pollen contains several allergenic proteins, with Jun a 1 being the dominant one, alongside Jun a 2, Jun a 3, and Jun a 7. When you inhale these, certain immune cells (B cells and plasma cells) start producing IgE antibodies that specifically recognize them. These antibodies stick to the surface of mast cells and basophils in your nose, eyes, and airways. The next time pollen arrives, the antibodies grab it, the cells release histamine and other chemicals, and you get symptoms within minutes.
The lab assay measures the concentration of these mountain cedar specific IgE antibodies circulating in your blood. A higher number generally means stronger sensitization, but the relationship between the number and how sick you feel is not perfectly linear. Some people with modest IgE levels have severe symptoms, and some with very high levels have mild ones.
Mountain cedar is unusual among tree pollens. In central Texas it can be the only allergen a person is sensitized to, and it produces seasonal allergic rhinitis severe enough to send people to urgent care. The condition often arrives suddenly during peak pollen days in December and January and resolves when the season ends.
Cedar specific IgE is the laboratory confirmation that your nasal symptoms are immunologic rather than viral, structural, or irritant. This matters because the treatments differ. A cold gets supportive care. A deviated septum needs surgery. Cedar allergy responds to allergen avoidance, antihistamines, intranasal steroids, anti-IgE biologics, and immunotherapy.
Cedar pollen is also a major trigger for itchy, red, watery eyes during the season. People with pollen-induced allergic conjunctivitis tend to have higher total tear IgE alongside elevated serum specific IgE. If your eye symptoms are seasonal and severe enough that over the counter drops barely touch them, confirming cedar sensitization helps justify stronger options like prescription antihistamine eye drops or systemic immunotherapy.
Some people sensitized to cedar pollen develop wheezing, coughing, and chest tightness during the season, even when they do not have year-round asthma. Clinical studies of cedar pollen-induced asthma describe adults whose airway symptoms appear only during the cedar season and resolve afterward. If you have new winter wheeze and a positive cedar IgE, your asthma plan likely needs seasonal adjustments rather than a year-round controller.
Mountain cedar shares allergen structures with other Cupressaceae family trees, including Japanese cedar (Cryptomeria japonica), cypress, and other juniper species. The major allergens Jun a 1, Jun a 2, and Jun a 3 are similar to Japanese cedar's Cry j 1, Cry j 2, and Cry j 3. This means a positive cedar IgE in someone who has traveled to or lived in cedar-rich regions of Japan, the Mediterranean, or the southwestern United States could reflect sensitization picked up anywhere along the way. It also means immunotherapy targeting one cedar species may help with related ones.
Allergen specific IgE is reported in kU/L (kilounits per liter), and most U.S. labs use the same ImmunoCAP scoring system. The classes below come from the standard ImmunoCAP scale used widely in clinical allergy testing. They are interpretation guidance rather than universal cutpoints, since the link between IgE level and clinical severity varies between people.
| Class | IgE Level (kU/L) | What It Suggests |
|---|---|---|
| 0 | Less than 0.10 | No detectable sensitization |
| I to II | 0.10 to 0.69 | Low sensitization, may or may not cause symptoms |
| III to IV | 0.70 to 17.4 | Moderate to high sensitization, symptoms likely with exposure |
| V to VI | 17.5 and above | Very high sensitization, strong symptoms typical with exposure |
Compare your results within the same lab over time for the most meaningful trend. Different lab platforms can report somewhat different numbers from the same blood sample.
A single IgE reading is a snapshot. The more useful question is whether your sensitization is rising, stable, or falling, and whether that lines up with what you are doing. People starting allergen immunotherapy often watch their specific IgE rise initially and then drift down over years, even as symptoms improve. Without a baseline, you cannot tell which phase you are in.
A reasonable cadence for someone managing cedar allergy is a baseline before any intervention, a follow up at one year if you start immunotherapy, and then annual checks if you are tracking response. If you are not on therapy but want to see how stable your sensitization is, every two to three years is enough.
If your cedar IgE is positive and your symptoms match the season, the next step is usually a treatment plan rather than more testing. Start with allergen avoidance during peak pollen days, layer in intranasal corticosteroids and oral antihistamines, and consider an allergist consultation for immunotherapy if symptoms are bothersome despite medications. If your cedar IgE is positive but you have no winter symptoms, no action is needed beyond awareness.
If your cedar IgE is negative but you still have severe winter symptoms, the search is not over. Consider testing for other regional pollens, dust mites, mold spores, and animal danders. A broader inhalant allergy panel or component-resolved diagnostic testing may identify the actual driver. An allergist can also rule out non-allergic rhinitis, which produces similar symptoms but does not respond to allergy treatments.
Evidence-backed interventions that affect your Mountain Cedar Tree IgE level
Mountain Cedar Tree IgE is best interpreted alongside these tests.